 |
Recombinant human placental growth factor |
|---|---|
| Trade Name | |
| Orphan Indication | Severe preeclampsia |
| USA Market Approval | USA |
| USA Designation Date | 2017-03-16 00:00:00 |
| Sponsor | Aggamin, LLC;3960 Broadway, Suite 330B;New York, New York, 10032 |
| |
Recombinant human placental growth factor |
|---|---|
| Trade Name | |
| Orphan Indication | Severe preeclampsia |
| USA Market Approval | USA |
| USA Designation Date | 2017-03-16 00:00:00 |
| Sponsor | Aggamin, LLC;3960 Broadway, Suite 330B;New York, New York, 10032 |